The future of point-of-care cardiac biomarker testing

The future of point-of-care cardiac biomarker testing

Higher global incidence of cardiovascular diseases (CVD) has led to an increased demand for cardiac biomarker testing. Point-of-care (POC) solutions have a rapid Turnaround Time (TAT) for reporting results of cardiac markers—making them appealing in emergency settings.

As POC tests challenge the dominance of lab-based tests to risk stratify and diagnose patients, find out where the use of POC cardiac testing is growing in this infographic.

Download free infographic

Simply fill in the form below to access this free infographic.

IVD Gateway

The go-to source for tracking and understanding market size, share and trends in IVD. Granular break-out of data and comprehensive coverage of international and domestic suppliers’ brand share across Asia, Europe, Latin America and the Middle East.